Papers - YONEYAMA TAKAHIRO
-
Comparison of efficacy and medical costs between upfront docetaxel and abiraterone treatments of metastatic hormone-sensitive prostate cancer patients in real-world practice: a multicenter retrospective study.
Ozaki K, Hatakeyama S, Narita S, Hata K, Yanagisawa T, Tanaka T, Togashi K, Hamaya T, Okamoto T, Yamamoto H, Yoneyama Ta, Hashimoto Y, Kimura T, Habuchi T, Ohyama C
World J Urol 2022.12
-
Associations of impaired grip strength and gait function with the severity of erectile dysfunction in men undergoing dialysis: a cross-sectional study．
Fujita N, Hatakeyama S, Momota M, Tobisawa Y, Yoneyama To, Okamoto T, Yamamoto H, Yoneyama Ta, Hashimoto Y, Yoshikawa K, Ohyama C
Aging Male 25 ( 1 ) 1 - 7 2022.11
-
Effects of apalutamide dose reduction on skin-related adverse events in patients with advanced prostate cancer: A multicenter retrospective study．
Oishi T, Hatakeyama S, Tabata R, Fujimori D, Kawashima Y, Tanaka R, Ishii N, Miura H, Tanaka T, Okamoto T, Yamamoto H, Yoneyama Ta, Hashimoto Y, Sato S, Ohyama C
Prostate 2022.10
-
Relationships of low-grade systemic inflammation and nutritional status with erectile dysfunction severity in men on dialysis．
Fujita N, Hatakeyama S, Momota M, Hamaya T, Tobisawa Y, Yoneyama To, Okamoto T, Yamamoto H, Yoneyama Ta, Hashimoto Y, Yoshikawa K, Ohyama C
Andrology 2022.8
-
Risk score-based substratification improves surveillance costs after transurethral resection of bladder tumor in patients with primary high-risk non-muscle-invasive bladder cancer．
Fujita N, Hatakeyama S, Momota M, Tobisawa Y, Yoneyama To, Yamamoto H, Ito H, Yoneyama Ta, Hashimoto Y, Yoshikawa K, Ohyama C
Sci Rep. 2022.8
-
TMEM2 expression is downregulated as bladder cancer invades the muscle layer．
Yoneyama MS, Yoneyama To, Tobisawa Y, Yamamoto H, Hatakeyama S, Yoneyama Ta, Hashimoto Y, Suzuki T, Ohyama C
Biochem Biophys Res Commun 2022.7
-
Effect of active anticancer therapy on serologic response to SARS-CoV-2 BNT162b2 vaccine in patients with urothelial and renal cell carcinoma．
10. Togashi K, Hatakeyama S, Yoneyama To, Hamaya T, Narita T, Fujita N, Iwamura H, Okamoto T, Yamamoto H, Yoneyama Ta, Hashimoto Y, Ohyama C
Int J Urol 2022.7
-
Impact of body size on skin-related adverse events in advanced prostate cancer treated with apalutamide: A multicenter retrospective study．
8. Sasaki D, Hatakeyama S, Tanaka T, Okamoto T, Yoneyama Ta, Ohyama C
Int J Urol 2022.7
-
Significance of pelvic lymph node dissection during radical prostatectomy in high-risk prostate cancer patients receiving neoadjuvant chemohormonal therapy．
Iwamura H, Hatakeyama S, Narita T, Ozaki Y, Konishi S, Horiguchi H, Kodama H, Kojima Y, Fujita N, Okamoto T, Tobisawa Y, Yoneyama To, Yamamoto H, Yoneyama Ta, Hashimoto Y, Ohyama C
Sci Rep. 2022.6
-
Association between Aortic Calcification Burden and the Severity of Erectile Dysfunction in Men Undergoing Dialysis: A Cross-Sectional Study．World J Mens Health.
Fujita N, Hatakeyama S, Momota M, Tobisawa Y, Yoneyama To, Okamoto T, Yamamoto H, Yoneyama Ta, Hashimoto Y, Yoshikawa K, Ohyama C
World J Mens Health 2022.5
-
Seroprevalence of SARS-CoV-2 spike IgG antibodies after the second BNT162b2 mRNA vaccine in Japanese kidney transplant recipients．
11. Hamaya T, Hatakeyama S, Yoneyama To, Tobisawa Y, Kodama H, Fujita T, Murakami R, Fujita N, Okamoto T, Yamamoto H, Yoneyama Ta, Hashimoto Y, Saitoh H, Narumi S, Tomita H, Ohyama C
Sci Rep 2022.4
-
Single immediate instillation of chemotherapy is associated with decreased recurrence and progression in patients with high-risk non-muscle-invasive bladder cancer who receive adjuvant induction bacillus Calmette-Guérin therapy．
Fujita N, Hatakeyama S, Momota M, Narita T, Tobisawa Y, Yoneyama To, Yamamoto H, Ito H, Yoneyama Ta, Hashimoto Y, Yoshikawa K, Ohyama C
Int J Urol 2022.2
-
Effect of upfront combination therapy on the overall survival of patients with metastatic castration-sensitive prostate cancer: A multicenter retrospective study．
4. Tanaka T, Hatakeyama S, Noro D, Togashi K, Yoneyama Ta, Ohyama C
Int J Urol 2022.2
-
Proportion of patients eligible for adjuvant immunotherapy in nonmetastatic clear-cell renal cell carcinoma treated with radical or partial nephrectomy．
Tanaka R, Hatakeyama S, Miura H, Hamaya T, Yoneyama Ta, Ohyama C
Int J Urol 2022.1
-
Characteristics of α2,3-sialyl N-glycosylated PSA as a biomarker for clinically significant prostate cancer in men with elevated PSA level．
24. Yoneyama T, Yamamoto H, Sutoh Yoneyama M, Tobisawa Y, Hatakeyama S, Narita T, Kodama H, Momota M, Ito H, Narita S, Tsushima F, Mitsuzuka K, Yoneyama T, Hashimoto Y, Duivenvoorden W, Pinthus JH, Kakeda S, Ito A, Tsuchiya N, Habuchi T, Ohyama C
Clin Cancer Res. 27 ( 22 ) 6164 - 6173 2021.11
-
Utility of total cell-free DNA levels for surgical damage evaluation in patients with urological surgeries．
28. Konishi S, Narita T, Hatakeyama S, Yoneyama T, Yoneyama MS, Tobisawa Y, Noro D, Sato T, Togashi K, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Ohyama C
Sci Rep. 11 ( 1 ) 2021.11
-
Oncologic and patient-reported outcomes after robot-assisted radical prostatectomy in men aged ≥75 years
Kyo Togashi , Shingo Hatakeyama , Teppei Okamoto , Yuta Kojima , Hiromichi Iwamura , Naoki Fujita , Takuma Narita , Itsuto Hamano , Tomoko Hamaya , Tohru Yoneyama , Hayato Yamamoto , Takahiro Yoneyama , Yasuhiro Hashimoto , Chikara Ohyama
Urol Oncol 39 ( 10 ) 2021.10
-
Comparison of pembrolizumab with conventional chemotherapy after first-line platinum-based chemotherapy for advanced urothelial carcinoma in real-world practice: A multicenter retrospective study．
16. Narita T, Hatakeyama S, Numakura K, Kobayashi M, Muto Y, Saito M, Narita S, Tanaka T, Noro D, Tokui N, Yoneyama T, Hashimoto Y, Habuchi T, Ohyama
Int J Url 28 ( 9 ) 899 - 905 2021.9
-
Prognostic significance of the Ki67 index and programmed death-ligand 1 expression after radical cystectomy in patients with muscle-invasive bladder cancer.
Hirotaka Horiguchi, Shingo Hatakeyama, Tohru Yoneyama, Mihoko Sutoh Yoneyama, Toshikazu Tanaka, Naoki Fujita, Teppei Okamoto, Hayato Yamamoto, Takahiro Yoneyama, Tadashi Yoshizawa, Yasuhiro Hashimoto, Toshiaki Kawaguchi, Chikara Ohyama
Urologic oncology 39 ( 4 ) 238.e9 - 238.e17 2021.4
-
Altered gut microbiome associated with overactive bladder and daily urinary urgency.
Teppei Okamoto, Shingo Hatakeyama, Atsushi Imai, Hayato Yamamoto, Tohru Yoneyama, Kazuyuki Mori, Takahiro Yoneyama, Yasuhiro Hashimoto, Shigeyuki Nakaji, Chikara Ohyama
World journal of urology 39 ( 3 ) 847 - 853 2021.3